These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22126431)

  • 21. Exploring the relationship between oxidative stress status and inflammatory markers during primary Sjögren's syndrome: A new approach for patient monitoring.
    Benchabane S; Sour S; Zidi S; Hadjimi Z; Nabila L; Acheli D; Bouzenad A; Belguendouz H; Touil-Boukoffa C
    Int J Immunopathol Pharmacol; 2024; 38():3946320241263034. PubMed ID: 38901876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The plasma concentration of advanced oxidation protein products and arterial stiffness in apparently healthy adults.
    Wykretowicz A; Adamska K; Krauze T; Guzik P; Szczepanik A; Rutkowska A; Wysoki H
    Free Radic Res; 2007 Jun; 41(6):645-9. PubMed ID: 17516236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum viscosity is a sensitive test for monitoring primary Sjögren syndrome.
    Lossjev GM; Khodarev NV; Vassiliev VI; Nassonova VA
    Int J Tissue React; 1993; 15(6):215-8. PubMed ID: 7522224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intense correlation between protein-conjugated acrolein and primary Sjögren's syndrome.
    Higashi K; Yoshida M; Igarashi A; Ito K; Wada Y; Murakami S; Kobayashi D; Nakano M; Sohda M; Nakajima T; Narita I; Toida T; Kashiwagi K; Igarashi K
    Clin Chim Acta; 2010 Mar; 411(5-6):359-63. PubMed ID: 19968980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum cytokine levels related to multiple dimensions of fatigue in patients with primary Sjogren's syndrome.
    Hartkamp A; Geenen R; Bijl M; Kruize AA; Godaert GL; Derksen RH
    Ann Rheum Dis; 2004 Oct; 63(10):1335-7. PubMed ID: 15361396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome.
    Skvarilová M; Bulava A; Stejskal D; Adamovská S; Bartek J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):83-7. PubMed ID: 16170393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative stress markers are increased since early stages of infection in syphilitic patients.
    Hébert-Schuster M; Borderie D; Grange PA; Lemarechal H; Kavian-Tessler N; Batteux F; Dupin N
    Arch Dermatol Res; 2012 Nov; 304(9):689-97. PubMed ID: 23011658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum levels of macrophage migration inhibitory factor in patients with primary Sjögren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Maaser C; Domschke W; Schlüter B; Becker H
    Arthritis Res Ther; 2007; 9(2):R43. PubMed ID: 17470266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA rheumatoid factor in primary Sjogren's syndrome.
    Peen E; Mellbye OJ; Haga HJ
    Scand J Rheumatol; 2009; 38(1):46-9. PubMed ID: 18942022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome.
    Szyszko EA; Brun JG; Skarstein K; Peck AB; Jonsson R; Brokstad KA
    Scand J Immunol; 2011 Jan; 73(1):18-28. PubMed ID: 21128999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.
    Li X; Li X; Qian L; Wang G; Zhang H; Wang X; Chen K; Zhai Z; Li Q; Wang Y; Harris DC
    J Rheumatol; 2007 Dec; 34(12):2438-45. PubMed ID: 18050367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein oxidation biomarkers in plasma of type 2 diabetic patients.
    Pandey KB; Mishra N; Rizvi SI
    Clin Biochem; 2010 Mar; 43(4-5):508-11. PubMed ID: 19941844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
    van de Merwe JP; van den Beemd MW; Hooijkaas H
    Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome.
    Li YN; Guo JP; He J; Liu X; Yin FR; Ding Y; Yao HH; Kang AJ; Li ZG
    Chin Med J (Engl); 2011 Aug; 124(16):2490-5. PubMed ID: 21933593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between IFN-alpha and primary Sjogren's syndrome.
    Zheng L; Zhang Z; Yu C; Tu L; Zhong L; Yang C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jan; 107(1):e12-8. PubMed ID: 19101478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study.
    Steinfeld SD; Tant L; Burmester GR; Teoh NK; Wegener WA; Goldenberg DM; Pradier O
    Arthritis Res Ther; 2006; 8(4):R129. PubMed ID: 16859536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced oxidation protein products: a novel marker of oxidative stress in ulcerative colitis.
    Baskol M; Baskol G; Koçer D; Ozbakir O; Yucesoy M
    J Clin Gastroenterol; 2008 Jul; 42(6):687-91. PubMed ID: 18574392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome.
    Girón-González JA; Baturone R; Soto MJ; Márquez M; Macías I; Montes de Oca M; Medina F; Chozas N; García-Pérez S
    Cell Immunol; 2009; 259(1):56-60. PubMed ID: 19540455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.